Glycemic control and complications of type 1 diabetes among children in Tanzania
- PMID: 33365257
- PMCID: PMC7749418
- DOI: 10.1016/j.jcte.2020.100245
Glycemic control and complications of type 1 diabetes among children in Tanzania
Abstract
Introduction: Knowledge on Type 1 Diabetes (T1D) in sub-Saharan Africa is scarce. This study aimed at assessing microvascular complications of Type 1 diabetes in young patients.
Method: A retrospective study based on medical recordings from 2010-2016 was done. 604 children and young adults with T1D were recruited from five hospitals with pediatric diabetes clinics. 559 patients aged 2-35 years with known date of birth were included. Clinical data on retinopathy and neuropathy were analyzed. There was no information on renal function/ nephropathy.
Results: Most data were missing. There was documentation on HbA1C, plasma glucose and complications in less than half of the patient files. Of those with registered HbA1c values (42.2%), 36% had HbA1c > 12.5%. There was high prevalence of retinopathy (21.5%) and neuropathy (29.4%) in spite of short mean duration of diabetes (6.2 ± 4.1 years).
Conclusion: Many patients with T1D in Tanzania have poor metabolic control. Microvascular complications are common already after a short duration of diabetes, but the results have to be interpreted with great caution because of study limitations. Better pediatric diabetes care as well as increased awareness of diabetes is needed. Studies in resource-poor countries need careful planning, if possible with prospective design.
Keywords: Complications; HbA1c; Neuropathy; Retinopathy; Tanzania; Type 1 diabetes.
© 2020 The Authors. Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86. - PubMed
-
- The Diabetes Control and Complications Trial Research Group The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44(8):968–983. - PubMed
-
- Nordwall M., Bojestig M., Arnqvist H.J., Ludvigsson J. Declining incidence of severeretinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes - The Linköping Diabetes Complications Study. Diabetologia. 2004;47(7):1266–1272. - PubMed
-
- Nordwall M., Abrahamsson M., Dhir M., Fredrikson M., Ludvigsson J. Arnqvist HJ Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden) Diabetes Care. 2015;38(2):308–315. doi: 10.2337/dc14-1203. Epub 2014 Dec 15. - DOI - PubMed
-
- Lind M., Svensson A.-M., Kosiborod M., Gudbjörnsdottir S., Pivodic A., Wedel H. Glycemic Control and Excess Mortality in Type 1 Diabetes. N Engl J Med [Internet]. 2014;371(21):1972–1982. http://www.nejm.org/doi/10.1056/NEJMoa1408214 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources